From Crib To Court: Trump Administration Summons Immigrant Infants
At least 70 infants have been ordered to appear in immigration court. Experts believe some were separated from their parents.
Shefali Luthra
Shefali Luthra was a correspondent for ³Ô¹Ï²»´òìÈ until June 2020.
Showing 101 - 120 of 259
-
-
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
By Shefali Luthra and Anna Gorman -
Immigrant Families Placed In Detention Centers Face Health Care Challenges
The Trump administration plans to detain immigrant families indefinitely in facilities run by the Department of Homeland Security, an agency with little experience in handling their complex needs.
By Shefali Luthra and Marisa Taylor -
Defendants In Diapers? Immigrant Toddlers Ordered To Appear In Court Alone
Children separated from their parents at the border are being ordered to appear for their own deportation proceedings, attorneys say.
By Christina Jewett and Shefali Luthra -
1 In 5 Immigrant Children Detained During ‘Zero Tolerance’ Border Policy Are Under 13
The White House’s latest immigration strategy has created challenges for the HHS Office of Refugee Resettlement, which is now responsible for more children — many far younger than in previous administrations.
By Shefali Luthra and Marisa Taylor -
Bubble Pop? Brownie Batter? Vapes’ Added Flavors Fuel E-Cig Debate
Vaping is becoming increasingly popular in the United States, especially among young people. This fact is triggering an unexpected divide within the public health community and complicating efforts to regulate the industry.
-
Vermont Legislators Pass A Drug Importation Law. So What?
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
-
When Credit Scores Become Casualties Of Health Care
The complexity of health insurance coverage rules, along with market trends that leave consumers open to more out-of-pocket costs, lead to mounting medical debt for consumers.
-
‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
-
Nation’s Top Doc Wants The Overdose Antidote Widely On Hand. Is That Feasible?
Surgeon General Jerome Adams urged more people to carry the drug naloxone, a lifesaving treatment for opioid overdoses. But this policy is tricky to implement.
By Shefali Luthra and Rachel Bluth -
Federal Appeals Court Puts Chill On Maryland Law To Fight Drug Price-Gouging
The decision in Maryland’s case could slow momentum for other states that are attempting to take action to curb high drug costs.
-
Congress Tackles The Opioid Epidemic. But How Much Will It Help?
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
-
Bill Of The Month: For Toenail Fungus, A $1,500 Prescription
How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.
-
Medicaid Is Rural America’s Financial Midwife
Medicaid payments allow struggling hospitals to maintain vital costly services such as maternity care.
-
Buried In The Budget Bill Are Belated Gifts For Some Health Care Providers
How physical and occupational therapists triumphed in a two-decade-long quest to overturn limits on their compensation.
-
Bad Bedside Manna: Bank Loans Signed In The Hospital Leave Patients Vulnerable
Hospitals increasingly team up with lending institutions to offer low- or no-interest loans to patients to make sure their bills get paid. But critics say the complexity of hospital pricing means consumers should be cautious.
-
In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation
Legislatures in blue and red states alike are considering proposals that would allow them to import prescription drugs from Canada.
-
Bipartisan Senate Budget Deal Boosts Health Programs
The agreement would add $2 billion to the National Institutes of Health and fund community health centers around the country. But it does not include provisions to help stabilize the federal health law’s marketplaces.
By Julie Rovner and Shefali Luthra -
Stalled Health Programs Await A Green Light On The Hill
With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
-
As States Target High Drug Prices, Pharma Targets State Lawmakers
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
By Jay Hancock and Shefali Luthra
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: